Product Images Brexpiprazole

Each film-coated tablet of Brexpiprazole NDC 60219-1650-3 contains 0.5mg of the active ingredient. The recommended dosage is outlined in the accompanying package insert. Store the tablets in a cool, dry place at temperatures between 20° to 25°C, with excursions up to 30°C permitted. Keep medication out of reach of children. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. in India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Lot and Exp. date information can be found in the designated area on the packaging.*

Each film-coated tablet of Brexpiprazole contains 1mg of the active ingredient. It is advised to refer to the package insert for dosage instructions. It should be stored between 20°C to 25°C, with occasional excursions allowed between 15°C to 30°C. The medication guide should be kept with the patient, and the drug should be kept out of reach of children. The drug is manufactured by Amneal Pharmaceuticals Pvt. Ltd in India and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. The lot number is 6/29/14585 with the revision date being 06-2019-00.*

This is a description of Brexpiprazole Tablets. It is advised by the pharmacist to dispense the medication guide to each patient. The tablets should be stored at a temperature between 20° to 25°C (68° to 77°F) and children should be kept out of reach. The usual dosage should be determined according to the package insert for indications and dosage information. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd. and the tablets are distributed by Amneal Pharmaceuticals LLC.*

This is a description of a medication, Brexpiprazole. The medication comes in a film-coated tablet form and is available in the dosage strength specified in the package insert. The tablets are stored at a temperature between 20°C to 25°C and excursions between 15°C to 30°C are allowed. The medication should be kept out of the reach of children. The medication is manufactured by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

Brexpiprazole Tablets are a type of oral solid dosage units containing 3mg of Brexpiprazole. It is recommended to store these tablets in a temperature range of 20°C to 25°C and keep them away from children. This medication is only available with a prescription and is accompanied by a medication guide. Amneal Pharmaceuticals Private Ltd is the manufacturer, and Amneal Pharmaceuticals LLC is the distributor of Brexpiprazole Tablets. Pharmacists should dispense the medication after taking into account the usual recommended dosage, which can be found in the package insert. The Lot and Exp. date information is printed in the Non-Varnish Area of the packaging.*

This text is a medication label for Brexpiprazole tablets. It includes information such as the NDC number, dosage instructions, and the manufacturer and distributor information. It also indicates that the medication guide should be dispensed to each patient, and it should be kept out of reach of children.*

This is a description of Brexpiprazole tablets, with NDC 60219-1654-3. Each film-coated tablet contains 4mg of Brexpiprazole. The recommended dosage is described in the accompanying package insert. The tablets need to be stored at a temperature between 20° to 25°C (68° to 77° Fahrenheit) with excursions between 15° to 30°C (59° to 86°F) permitted. The medication guide should be dispensed by the pharmacist to patients. The tablets are made by Amneal Pharmaceuticals, located in Ahmedabad 382213, India, and are distributed in the USA by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.*

This is a medicine label for Brexpiprazole tablets. The label provides information about the appropriate dosage, storage conditions, and dispensing instructions. It also includes the manufacturer's details and a patent notice. Additionally, the NDC number, which is unique to this medicine, is given. The label suggests that patients should receive a Medication Guide, which must be dispensed by the pharmacist.*

The text is related to Brexpiprazole PK which is measuring fold change and 90% confidence intervals for renal and hepatic impairment. Furthermore, the text includes a population description based on gender and age with corresponding percentages. The last line refers to change relative to reference.*

This text appears to be a list of various substances and their effects, as well as some sort of table showing fold change and confidence intervals. The substances listed include inhibitors of certain enzymes (CYP1A2, CYP2D6, and CYP2C9), an inducer of CYP3A4, and a medication that increases gastric pH. The table seems to show changes relative to a reference (without an interacting drug) in cmax and aucer. Overall, it appears to be related to pharmacology and drug interactions.*

This appears to be a table showing the effect of certain substances on various enzymes and substrates. It includes information on fold change and confidence intervals for analytes related to Dextromethorphan, Fexofenadine, Bupropion, Lovastatin, Rosuvastatin, and Hydroxyacid.*

Brexpiprazole Tablets are a medication that come in film-coated form containing 0.25mg of Brexpiprazole. The usual dosage is detailed in the package insert along with indication and dosage information. It is recommended to store the tablets between 20° to 25°C (68° to 77°1), with short excursions allowed between 15° to 30°C (59° to 86°F). The medication guide should be provided to each patient by the pharmacist. The tablets are produced by Amneal Pharmaceuticals Pvt. Ltd. in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ 08807. The product is not available for purchase without a prescription.*